TP53 mutations, human papilloma virus DNA and inflammation markers in esophageal squamous cell carcinoma from the Rift Valley, a high-incidence area in Kenya

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Patel, Kirtika ^a   Mining, Simeon ^a   Wakhisi, Johnston ^a   Gheit, Tarik ^b   Tommasino, Massimo ^b   Martel Planche, Ghislaine ^b   Hainaut, Pierre ^b   Abedi Ardekani, Behnoush ^b,c  

^a MOI UNIVERSITY   (Kenya)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; NICOTIANA TABACUM;

EID: 80054985277     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-469     Document Type: Article

References (40)

1. Global cancer statistics, 2002. Parkin DM, Bray F, Ferlay J, Pisani P, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078 (Pubitemid 40372904)
2. Esophageal cancer: cases and causes (part I). Lambert R, Hainaut P, Endoscopy 2007 39 550 555 10.1055/s-2007-966530 17554654 (Pubitemid 46978049)
3. Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Abedi-Ardekani B, Kamangar F, Hewitt SM, Hainaut P, Sotoudeh M, Abnet CC, Taylor PR, Boffetta P, Malekzadeh R, Dawsey SM, Gut 2010 59 1178 1183 10.1136/gut.2010.210609 20584779
4. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, Merat S, Pourshams A, Marjani HA, Ebadati A, Sotoudeh M, Boffetta P, Malekzadeh R, Dawsey SM, Cancer Epidemiol Biomarkers Prev 2008 17 3062 3068 10.1158/1055-9965.EPI-08-0558 18990747
5. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, bedi-Ardekani B, Merat S, Nasseri-Moghaddam S, Semnani S, Sepehr A, Wakefield J, Moller H, Abnet CC, Dawsey SM, Boffetta P, Malekzadeh R, Int J Epidemiol 2009 38 978 988 10.1093/ije/dyp195 19416955
6. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, bedi-Ardekani B, Merat S, Vahedi H, Semnani S, Abnet CC, Brennan P, Moller H, Saidi F, Dawsey SM, Malekzadeh R, Boffetta P, BMJ 2009 338 929 10.1136/bmj.b929 19325180
7. Esophageal cancer in Northeastern Iran: a review. Kamangar F, Malekzadeh R, Dawsey SM, Saidi F, Arch Iran Med 2007 10 70 82 17198458 (Pubitemid 46188969)
8. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, Shakeri R, Pourshams A, Marjani HA, Nouraie M, Khatibian M, Semnani S, Ye W, Boffetta P, Dawsey SM, Malekzadeh R, Br J Cancer 2008 98 1857 1863 10.1038/sj.bjc.6604369 18475303 (Pubitemid 351748837)
9. Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. Wang X, Tian X, Liu F, Zhao Y, Sun M, Chen D, Lu C, Wang Z, Shi X, Zhang Q, Zhang D, Shen Z, Li F, Harris CC, Cai H, Ke Y, BMC Cancer 2010 10 19 10.1186/1471-2407-10-19 20078887
10. Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China. Chang F, Syrjanen S, Shen Q, Ji HX, Syrjanen K, Int J Cancer 1990 45 21 25 10.1002/ijc.2910450106 2153638 (Pubitemid 20032092)
11. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Koshiol J, Wei WQ, Kreimer AR, Chen W, Gravitt P, Ren JS, Abnet CC, Wang JB, Kamangar F, Lin DM, von Knebel-Doeberitz M, Zhang Y, Viscidi R, Wang GQ, Gillison ML, Roth MJ, Dong ZW, Kim E, Taylor PR, Qiao YL, Dawsey SM, Int J Cancer 2010 127 93 100 10.1002/ijc.25023 19918949
12. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. de Villiers EM, Lavergne D, Chang F, Syrjanen K, Tosi P, Cintorino M, Santopietro R, Syrjanen S, Int J Cancer 1999 81 225 228 10.1002/(SICI)1097-0215(19990412)81:2<225::AID- IJC10>3.0.CO;2-0 10188723 (Pubitemid 29144751)
13. Carcinogens and endemic squamous cancer of the oesophagus in Transkei, South Africa. Environmental initiation is the dominant factor; tobacco or other carcinogens of low potency or concentration are sufficient for carcinogenesis in the predisposed mucosa. Sammon AM, Med Hypotheses 2007 69 125 131 10.1016/j.mehy.2006.11.011 17258402 (Pubitemid 46686943)
14. Traditional home-brewed beer consumption and iron status in patients with esophageal cancer and healthy control subjects from Transkei, South Africa. Matsha T, Brink L, van RS, Hon D, Lombard C, Erasmus R, Nutr Cancer 2006 56 67 73 10.1207/s15327914nc5601-9 17176219 (Pubitemid 46173415)
15. Maize meal predisposes to endemic squamous cancer of the oesophagus in Africa: breakdown of esterified linoleic acid to the free form in stored meal leads to increased intragastric PGE2 production and a low-acid reflux. Sammon AM, Iputo JE, Med Hypotheses 2006 67 1431 1436 10.1016/j.mehy.2006.05.037 16824700 (Pubitemid 44442640)
16. Oesophageal cancer in Africa. Hendricks D, Parker MI, IUBMB Life 2002 53 263 268 10.1080/15216540212643 12121007 (Pubitemid 34728938)
17. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history. Bennett WP, von Brevern MC, Zhu SM, Bartsch H, Muehlbauer KR, Hollstein MC, Cancer Epidemiol Biomarkers Prev 1997 6 963 966 9367071 (Pubitemid 27481646)
18. Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients. Lam KY, Tsao SW, Zhang D, Law S, He D, Ma L, Wong J, Int J Cancer 1997 74 212 219 10.1002/(SICI)1097-0215(19970422)74: 2<212::AID-IJC13>3.0.CO;2-F 9133458 (Pubitemid 27234513)
19. Oesophageal cancer: a common malignancy in young people of Bomet District, Kenya. White RE, Abnet CC, Mungatana CK, Dawsey SM, Lancet 2002 360 462 463 10.1016/S0140-6736(02)09639-3 12241722 (Pubitemid 34880147)
20. Burden and pattern of cancer in Western Kenya. Tenge CN, Kuremu RT, Buziba NG, Patel K, Were PA, East Afr Med J 2009 86 7 10 19530542
21. Esophageal cancer in north rift valley of Western Kenya. Wakhisi J, Patel K, Buziba N, Rotich J, Afr Health Sci 2005 5 157 163 16006224 (Pubitemid 44255014)
22. Frequent occurrence of esophageal cancer in young people in western Kenya. Parker RK, Dawsey SM, Abnet CC, White RE, Dis Esophagus 2010 23 128 135 10.1111/j.1442-2050.2009.00977.x 19473205
23. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran. Sepehr A, Taniere P, Martel-Planche G, Zia'ee AA, Rastgar-Jazii F, Yazdanbod M, Etemad-Moghadam G, Kamangar F, Saidi F, Hainaut P, Oncogene 2001 20 7368 7374 10.1038/sj.onc.1204912 11704866 (Pubitemid 33078207)
24. Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Vaninetti NM, Geldenhuys L, Porter GA, Risch H, Hainaut P, Guernsey DL, Casson AG, Mol Carcinog 2008 47 275 285 10.1002/mc.20382 17849424 (Pubitemid 351500153)
25. Cross-talks between cyclooxygenase-2 and tumor suppressor protein p53: Balancing life and death during inflammatory stress and carcinogenesis. de Moraes E, Dar NA, de Moura Gallo CV, Hainaut P, Int J Cancer 2007 121 929 937 10.1002/ijc.22899 17582597 (Pubitemid 47101627)
26. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, Canzian F, Tommasino M, J Clin Microbiol 2006 44 2025 2031 10.1128/JCM.02305-05 16757593 (Pubitemid 43902148)
27. p53 and p16/CDKN2 gene mutations in esophageal tumors from a high-incidence area in South Africa. Gamieldien W, Victor TC, Mugwanya D, Stepien A, Gelderblom WC, Marasas WF, Geiger DH, van Helden PD, Int J Cancer 1998 78 544 549 10.1002/(SICI)1097-0215(19981123)78:5<544::AID-IJC3>3.0. CO;2-T 9808520 (Pubitemid 28507175)
28. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, Taghavi N, Marjani HA, Merat S, Nasseri-Moghaddam S, Pourshams A, Nouraie M, Khatibian M, Abedi B, Brazandeh MH, Ghaziani R, Sotoudeh M, Dawsey SM, Abnet CC, Taylor PR, Malekzadeh R, Br J Cancer 2004 90 1402 1406 10.1038/sj.bjc.6601737 15054463 (Pubitemid 38586269)
29. Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China. Cao W, Chen X, Dai H, Wang H, Shen B, Chu D, McAfee T, Zhang ZF, Cancer 2004 101 834 844 10.1002/cncr.20437 15305417 (Pubitemid 39030942)
30. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS, Cancer Res 1994 54 4342 4346 8044781
31. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Hu N, Huang J, Emmert-Buck MR, Tang ZZ, Roth MJ, Wang C, Dawsey SM, Li G, Li WJ, Wang QH, Han XY, Ding T, Giffen C, Goldstein AM, Taylor PR, Clin Cancer Res 2001 7 883 891 11309337 (Pubitemid 32708725)
32. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China. Lung ML, Chan WC, Zong YS, Tang CM, Fok CL, Wong KT, Chan LK, Lau KW, Cancer Epidemiol Biomarkers Prev 1996 5 277 284 8722219
33. Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France). Breton J, Sichel F, Abbas A, Marnay J, Arsene D, Lechevrel M, Mutagenesis 2003 18 299 306 10.1093/mutage/18.3.299 12714698 (Pubitemid 36592425)
34. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M, Hum Mutat 2007 28 622 629 10.1002/humu.20495 17311302 (Pubitemid 46744292)
35. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Kreimer AR, Clifford GM, Boyle P, Franceschi S, Cancer Epidemiol Biomarkers Prev 2005 14 467 475 10.1158/1055-9965.EPI-04-0551 15734974 (Pubitemid 40270113)
36. Human papillomavirus oncoproteins: pathways to transformation. Moody CA, Laimins LA, Nat Rev Cancer 2010 10 550 560 10.1038/nrc2886 20592731
37. Absence of human papillomavirus in esophageal carcinomas from southwestern Kenya. White RE, Mungatana C, Mutuma G, Robert ME, Daniel RW, Topazian MD, Shah KV, Dis Esophagus 2005 18 28 30 10.1111/j.1442-2050.2005. 00452.x 15773838 (Pubitemid 40542791)
38. Simple intervention method to reduce fumonisin exposure in a subsistence maize-farming community in South Africa. van der WL, Shephard GS, Rheeder JP, Burger HM, Gelderblom WC, Wild CP, Gong YY, Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2010 27 1582 1588 20835935
39. Mycotoxins and human disease: a largely ignored global health issue. Wild CP, Gong YY, Carcinogenesis 2010 31 71 82 10.1093/carcin/bgp264 19875698
40. Incidence of Fusarium spp. and levels of fumonisin B1 in maize in western Kenya. Kedera CJ, Plattner RD, Desjardins AE, Appl Environ Microbiol 1999 65 41 44 9872757 (Pubitemid 29029616)